Clinical efficacy of low‐dose Perampanel correlates with neurophysiological changes in familial adult myoclonus epilepsy 2
Abstract Familial adult myoclonus epilepsy (FAME) management relies on antiseizure medications (ASMs), which inadequately address myoclonus and cortical tremor. This study evaluates Perampanel (PER), an AMPA‐receptor antagonist, for treating FAME symptoms. Fifteen FAME2 patients participated in an o...
Saved in:
Main Authors: | Antonietta Coppola, Claudia Cuccurullo, Gianmaria Senerchia, Marica Rubino, Liana Veneziano, Francesco Brancati, Luigi Baratto, Valentina Virginia Iuzzolino, Leonilda Bilo, Pasquale Striano, Raffaele Dubbioso |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-02-01
|
Series: | Epilepsia Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/epi4.13100 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perampanel-associated Psychiatric Problems
by: Anil Kakunje, et al.
Published: (2024-01-01) -
Comparison of intraoperative neurophysiological monitoring between propofol and remimazolam during total intravenous anesthesia in the cervical spine surgery: a prospective, double-blind, randomized controlled trial
by: Myoung Hwa Kim, et al.
Published: (2025-02-01) -
Drug-Induced Myoclonus: A Systematic Review
by: Jamir Pitton Rissardo, et al.
Published: (2025-01-01) -
Visual and somatosensory evoked potentials abnormalities among Behçet’s disease patients and their relation to disease activity, severity and antiphospholipid antibodies: a cross-sectional study
by: Ghada S. Nageeb, et al.
Published: (2025-01-01) -
Myoclonus
by: R. Rimšienė, et al.
Published: (2020-12-01)